MADRID, Spain – March, 2026 –
Corify Care secures new funding to launch ATENEA, a project that introduces real-time Digital Twin technology to the electrophysiology lab, empowering clinicians to simulate and optimize ablation strategies before the intervention.
Corify Care secures new funding to launch ATENEA, a groundbreaking project that introduces real-time Digital Twin technology to the electrophysiology lab, empowering clinicians to simulate and optimize ablation strategies before the intervention. At Corify Care, our mission is to end “blind” arrhythmia treatments by providing clinicians with unprecedented Clinical Clarity. Today, we are incredibly proud to announce a major milestone in our technological roadmap: the official launch of the ATENEA Project.
ATENEA represents the highly anticipated Phase 2 of the Corify platform. This initiative focuses on the development and integration of AI-driven Digital Twin technology, designed to assist cardiac electrophysiologists in the diagnosis and treatment of complex arrhythmias like Atrial Fibrillation (AF) and Ventricular Tachycardia (VT).
The Power of the Digital Twin
Currently, clinicians face the challenge of treating arrhythmias without being able to fully predict how the heart will respond to a specific ablation pattern. ATENEA changes this paradigm. By leveraging our ultra-fast Global Cardiac Mapping technology, this technology uses advanced artificial intelligence to generate a highly accurate, patient-specific virtual replica of the heart in just minutes.
This interactive Digital Twin allows physicians to:
- Visualize the entire heart’s electrical activity in a single heartbeat.
- Simulate different ablation strategies in real-time.
- Predict the success rate of the intervention before making the first burn.
The Ultimate Complement to Catheter Ablation
Precision is not about mapping more; it is about mapping smarter. This technology is designed to seamlessly integrate into existing hospital infrastructures. We do not seek to replace invasive catheters; instead, our technology acts as their ultimate guide. By providing a complete, panoramic view of the heart and predicting the most effective treatment pathways, this technology empowers clinical teams to minimize procedure times, reduce unnecessary lesions, and significantly improve patient outcomes.
ATENEA project Grant 59.418069.9/25 is funded by Dirección General de Investigación e Innovación Tecnológica. Consejería de Educación, Ciencia y Universidades, Comunidad de Madrid and Feder EU. We extend our deepest gratitude to our funding partners for supporting the future of European medical innovation.